An interventional study of Ultrasound-Guided Intrafascial Injection (10 ml) and Ultrasound-Guided Extrafascial Injection (10 ml) in Diaphragmatic Paralysis, Shoulder Surgery and Postoperative Pain, sponsored by Ankara Etlik City Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary objective of this prospective clinical study is to evaluate the incidence of hemidiaphragmatic paralysis when the phrenic nerve is utilized as a primary sonographic landmark during interscalene brachial plexus blocks. While interscalene blocks provide excellent analgesia for shoulder surgeries, they are frequently associated with unintended phrenic nerve blockade, leading to diaphragmatic paresis or paralysis. This study hypothesizes that utilizing the phrenic nerve as a specific landmark to guide local anesthetic injection will [reduce] the frequency of diaphragmatic paralysis while maintaining adequate surgical anesthesia.
37 studies on the registry are indexed under Respiratory Paralysis; 9 are open to participants now.
This study's planned enrollment of 50 is close to the median of 48 across 20 interventional studies indexed under Respiratory Paralysis.
Browse Respiratory Paralysis studies →Ankara Etlik City Hospital is the lead sponsor of 180 studies on the registry; 78 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In this group, interscalene anatomical structures and the phrenic nerve will be visualized under ultrasound guidance. A volume of 10 ml of local anesthetic solution will be injected directly into the brachial plexus sheath (intrafascial plane)
Procedure: Ultrasound-Guided Intrafascial Injection (10 ml)
In this group, interscalene anatomical structures and the phrenic nerve will be visualized under ultrasound guidance. A volume of 10 ml of local anesthetic solution will be injected outside the brachial plexus nerve sheath (extrafascial plane)
Procedure: Ultrasound-Guided Extrafascial Injection (10 ml)
Under ultrasound guidance, the interscalene brachial plexus and the phrenic nerve will be directly visualized on the anterior scalene muscle to be used as a landmark. A total of 10 ml of \[Local anesthetic medication name, e.g., 0.5% Bupivacaine\] solution will be injected strictly into the intrafascial plane, inside the nerve sheath
Under ultrasound guidance, the interscalene brachial plexus and the phrenic nerve will be directly visualized on the anterior scalene muscle to be used as a landmark. A total of 10 ml of \[Local anesthetic medication name, e.g., 0.5% Bupivacaine\] solution will be injected strictly into the extrafascial plane, outside the nerve sheath
Incidence of Transient Hemidiaphragmatic Paralysis
The incidence of transient diaphragmatic paralysis (phrenic nerve paresis) will be evaluated by measuring diaphragmatic excursion using diaphragm ultrasonography
Time frame: At postoperative minute 0 and minute 30
Postoperative Pain Scores
Postoperative pain severity will be assessed using the Numeric Rating Scale (NRS). The scale ranges from 0 to 10, where 0 represents 'no pain' and 10 represents 'worst imaginable pain'. Higher scores indicate a worse outcome (more severe pain)
Time frame: Postoperative 1st, 3rd, 6th, 12th, and 24th hours
Postoperative Total Opioid Consumption
The amount of total opioid consumption will be recorded during the postoperative follow-up period
Time frame: Postoperative 1st, 3rd, 6th, 12th, and 24th hours
Incidence of Dyspnea
The presence of shortness of breath (dyspnea) complaints from the patients will be evaluated and recorded
Time frame: Up to 24 hours postoperatively
Start is estimated for Oct 2026; primary completion for Feb 2027, 3 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.